Pfizer (BUE:PFE) Cyclically Adjusted Book per Share: ARS5,784.33 (As of Mar. 2026)


BUE:PFE Pfizer Inc BUE:PFE
56 GF Score
Price ARS9,600.00
GF Value ARS10,278.95
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Cyclically Adjusted Book per Share?

Pfizer BUE:PFE +2.18% 56 Cyclically Adjusted Book per Share is ARS5,784.33 as of Mar. 2026. GuruFocus rates BUE:PFE with a GF Score™ of 56/100 and a GF Value™ of ARS10,278.95 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Pfizer's adjusted book value per share for the three months ended in Mar. 2026 was ARS44,212.417. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ARS5,784.33 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pfizer's average Cyclically Adjusted Book Growth Rate was 4.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 3.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 3.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Pfizer was 27.40% per year. The lowest was 0.90% per year. And the median was 8.00% per year.

As of today (2026-07-03), Pfizer's current stock price is ARS9600.00. Pfizer's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ARS5,784.33. Pfizer's Cyclically Adjusted PB Ratio of today is 1.66.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.44. And the median was 2.87.


Pfizer  (BUE:PFE) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pfizer's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=9600.00/5784.33
=1.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Pfizer was 4.70. The lowest was 1.44. And the median was 2.87.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Pfizer Cyclically Adjusted Book per Share Related Terms


Pfizer Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Pfizer's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Cyclically Adjusted Book per Share Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,285.71 2,362.92 7,036.38 4,423.58 5,889.08

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,990.11 4,667.30 5,941.70 5,889.08 5,784.33

BUE:PFE vs GILD, BMY, AMGN: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted PB Ratio falls into.


BUE:PFE
56GF Score
Pfizer Inc BUE:PFE
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=44212.417/330.2130*330.2130
=44,212.417

Current CPI (Mar. 2026) = 330.2130.

Pfizer Quarterly Data

Book Value per Share CPI Adj_Book
201606 289.217 241.018 396.249
201609 311.105 241.428 425.514
201612 310.887 241.432 425.208
201703 302.441 243.801 409.637
201706 323.503 244.955 436.100
201709 357.178 246.819 477.860
201712 455.335 246.524 609.910
201803 475.311 249.554 628.938
201806 593.563 251.989 777.821
201809 907.791 252.439 1,187.473
201812 836.118 251.233 1,098.968
201903 827.059 254.202 1,074.365
201906 956.719 256.143 1,233.378
201909 1,316.197 256.759 1,692.737
201912 1,363.668 256.974 1,752.321
202003 1,453.553 258.115 1,859.567
202006 1,586.043 257.797 2,031.568
202009 1,743.685 260.280 2,212.185
202012 1,848.862 260.474 2,343.874
202103 2,209.971 264.877 2,755.094
202106 2,370.094 271.696 2,880.557
202109 2,638.056 274.310 3,175.679
202112 2,774.565 278.802 3,286.194
202203 3,165.814 287.504 3,636.099
202206 3,752.454 296.311 4,181.786
202209 4,586.984 296.808 5,103.238
202212 5,711.384 296.797 6,354.422
202303 7,067.301 301.836 7,731.731
202306 8,419.685 305.109 9,112.447
202309 12,016.314 307.789 12,891.764
202312 11,382.945 306.746 12,253.775
202403 27,438.711 312.332 29,009.577
202406 27,718.724 314.175 29,133.709
202409 30,962.880 315.301 32,427.254
202412 31,439.982 315.605 32,895.204
202503 33,879.910 319.799 34,983.182
202506 37,043.050 322.561 37,921.809
202509 44,331.651 324.800 45,070.466
202512 44,150.180 324.054 44,989.302
202603 44,212.417 330.213 44,212.417

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ARS5,784.33 mean?
Pfizer (BUE:PFE) has a Cyclically Adjusted Book per Share of ARS5,784.33 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pfizer and its competitors.
Is Pfizer's Cyclically Adjusted Book per Share too high?
Pfizer's current Cyclically Adjusted Book per Share is ARS5,784.33. Overall, Pfizer has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Cyclically Adjusted Book per Share compare to GILD and BMY?
Pfizer's Cyclically Adjusted Book per Share of ARS5,784.33 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Pfizer and its competitors. Pfizer's current Cyclically Adjusted Book per Share is ARS5,784.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (BUE:PFE) is currently considered Fairly Valued. The stock's GF Value™ is ARS10,278.95, compared to a current price of ARS9,600.00 — trading 6.6% below its estimated fair value. The current Cyclically Adjusted Book per Share is ARS5,784.33. Pfizer's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Pfizer (BUE:PFE), the current Cyclically Adjusted Book per Share is ARS5,784.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (BUE:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of ARS9,600.00 is trading 6.6% below its estimated GF Value™ of ARS10,278.95. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for BUE:PFE:

  • Cyclically Adjusted Book per Share: ARS5,784.33
  • GF Value™: ARS10,278.95 vs. price of ARS9,600.00 (6.6% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the BUE:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
56GF Score

Get the complete analysis for BUE:PFE

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS9,600.00
Price
ARS10,278.95
GF Value